CD44 / PAK1/AKT signaling promote resistance to FGFR1 inhibition in lung cancer
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Studying resistance to FGFR1 inhibition in Lung Cancer
应用场景：
创建时间：
2022-05-21
相关数据集
siRNA Administration Against AFP Inhibits Hepatocellular Carcinoma Proliferation in Vitro and Progression in Mice
Increased α-fetoprotein (AFP) levels have been reported to predict a poor prognosis in hepatocellular carcinoma (HCC). We assessed the mechanism of AFP involvement in the progression of HCC and determ
NIAID Data Ecosystem80
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
BackgroundThe sustained clinical activity of the BRAF inhibitor vemurafenib (PLX4032/RG7204) in patients with BRAFV600 mutant melanoma is limited primarily by the development of acquired resistance le
Figshare2016-01-18 更新50
Molecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer
Molecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer
integrated proteome resources20
Crystal structure of BRAF/MEK1 complex with NST-628 and an active RAF dimer
Crystal structure of BRAF/MEK1 complex with NST-628 and an active RAF dimer Descriptor: 1,2-ETHANEDIOL, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Dual specificity mitogen-activated protein kinase kina
Protein Data Bank Japan2024-07-10 更新60
First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials
Purpose A variety of targeted drug were developed and proved effective and safe in clinical trials. Our study aims to compare the efficacies and safety of different targeted drugs in advanced hepatoce
NIAID Data Ecosystem50
